175 related articles for article (PubMed ID: 12052284)
1. Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
Redman AR; Allen LC
Curr Atheroscler Rep; 2002 Jul; 4(4):319-25. PubMed ID: 12052284
[TBL] [Abstract][Full Text] [Related]
2. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
Hankey GJ
Stroke; 2002 Jun; 33(6):1723-6. PubMed ID: 12053018
[No Abstract] [Full Text] [Related]
3. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
4. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
6. The role of warfarin and aspirin in secondary prevention of stroke.
Elkind MS
Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359
[TBL] [Abstract][Full Text] [Related]
7. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
Khan M; Kamal AK
J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
[No Abstract] [Full Text] [Related]
8. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
Evans A; Perez I; Yu G; Kalra L
Stroke; 2001 Dec; 32(12):2828-32. PubMed ID: 11739981
[TBL] [Abstract][Full Text] [Related]
9. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.
Longstreth WT; Kronmal RA; Thompson JL; Christenson RH; Levine SR; Gross R; Brey RL; Buchsbaum R; Elkind MS; Tirschwell DL; Seliger SL; Mohr JP; deFilippi CR
Stroke; 2013 Mar; 44(3):714-9. PubMed ID: 23339958
[TBL] [Abstract][Full Text] [Related]
10. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
Fisher M
Stroke; 2009 May; 40(5):1944-5. PubMed ID: 19299634
[No Abstract] [Full Text] [Related]
11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
12. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
[TBL] [Abstract][Full Text] [Related]
13. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants in patients with coronary artery disease.
Anand SS; Yusuf S
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):62S-69S. PubMed ID: 12644343
[TBL] [Abstract][Full Text] [Related]
16. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Kumar G; Goyal MK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulant therapy for the prevention of stroke.
Powers WJ
N Engl J Med; 2001 Nov; 345(20):1493-5. PubMed ID: 11794201
[No Abstract] [Full Text] [Related]
18. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
[TBL] [Abstract][Full Text] [Related]
19. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
[TBL] [Abstract][Full Text] [Related]
20. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
